These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38250546)

  • 21. Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients.
    Hidayat YM; Darmadi A E; Rachmayati S; Kusumah WP; Djuwantono T; Pramatirta AY; Suardi D
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3325-3329. PubMed ID: 33247691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folinic acid rescue during methotrexate treatment for low-risk gestational trophoblastic neoplasia - How much is just right?
    Poli JG; Paiva G; Freitas F; Mora P; Velarde LGC; Junior JA; Filho JR; Elias KM; Horowitz NS; Braga A; Berkowitz RS
    Gynecol Oncol; 2021 Sep; 162(3):638-644. PubMed ID: 34266689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the efficiency and safety of chemotherapy as a therapeutic method for recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis.
    Jiang TY; Ren JJ; Zhang Y; Zhao Y; Feng XL
    Medicine (Baltimore); 2021 Jun; 100(24):e26263. PubMed ID: 34128856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.
    Shah NT; Barroilhet L; Berkowitz RS; Goldstein DP; Horowitz N
    J Reprod Med; 2012; 57(5-6):211-8. PubMed ID: 22696815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of the Surgery-First Approach Compared to the Chemotherapy-First Approach for Treating Low-Risk Gestational Trophoblastic Neoplasia: A Systematic Review and Meta-Analysis.
    Kamijo K; Ishida K; Oide S; Anan K; Taito S; Kataoka Y; Chikazawa K
    Cureus; 2023 Sep; 15(9):e45726. PubMed ID: 37868570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend.
    Braga A; de Souza Hartung Araújo C; Mora PAR; Paulino E; de Melo AC; Velarde GC; Dos Santos Esteves APV; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2020 Mar; 156(3):598-605. PubMed ID: 31928806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN).
    Winter MC; Tidy JA; Singh K; Sarwar N; Aguiar X; Seckl MJ
    Gynecol Oncol; 2023 Aug; 175():66-71. PubMed ID: 37327541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
    Kanno T; Matsui H; Akizawa Y; Usui H; Shozu M
    J Gynecol Oncol; 2018 Nov; 29(6):e89. PubMed ID: 30207097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.
    Faaborg L; Niemann I; Ostenfeld EB; Hansen ES; Sunde L; Lindegaard JC
    Acta Oncol; 2016; 55(2):234-9. PubMed ID: 26106854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial.
    Chen L; Xi L; Jiang J; Yin R; Qu P; Li X; Wan X; Chen Y; Hu D; Mao Y; Pan Z; Cheng X; Wang X; Li Q; Weng D; Zhang X; Zhang H; Ping Q; Liu X; Xie X; Kong B; Ma D; Lu W
    Front Med; 2022 Apr; 16(2):276-284. PubMed ID: 34181195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia.
    Li L; Wan X; Feng F; Ren T; Yang J; Zhao J; Jiang F; Xiang Y
    BMC Cancer; 2018 May; 18(1):585. PubMed ID: 29792175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-risk gestational trophoblastic neoplasia: A single-center experience from Saudi Arabia.
    Alobaid A; Ahmeed S; Abuzaid M; Aldakhil L; Abu-Zaid A
    Avicenna J Med; 2019; 9(3):89-93. PubMed ID: 31404135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
    Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
    Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-Day Intravascular Methotrexate Versus Biweekly Actinomycin-D in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia: A Clinical Randomized Trial.
    Yarandi F; Mousavi A; Abbaslu F; Aminimoghaddam S; Nekuie S; Adabi K; Hanjani P
    Int J Gynecol Cancer; 2016 Jun; 26(5):971-6. PubMed ID: 27101581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
    Cagayan MS; Gacoba MC
    J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Cost-Effectiveness Between Actinomycin D Versus Methotrexate-Folinic Acid in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia.
    Lertkhachonsuk AA; Hanvoravongchai P
    J Reprod Med; 2016; 61(5-6):230-4. PubMed ID: 27424364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study.
    Frijstein MM; Lok C; van Trommel NE; Ten Kate-Booij MJ; Massuger L; van Werkhoven E; Short D; Aguiar X; Fisher RA; Kaur B; Sarwar N; Sebire NJ; Seckl MJ
    BJOG; 2020 Feb; 127(3):389-395. PubMed ID: 31794098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia.
    Sheikhhasani S; Abdolrazaghnejad A; Mousavi AS; Akhavan S; Zamani N; Feizabad E
    Caspian J Intern Med; 2023; 14(1):47-52. PubMed ID: 36741497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.